HeartBeam shifts focus to heart attack detection, away from arrhythmia

Go back to HeartBeam shifts focus to heart attack detection, away from arrhythmia

HeartBeam, Inc. Letter to Shareholders

September 21, 2026 8:31 AM EDT

SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today issued a letter to shareholders from its Executive Chairman Richard Ferrari, and President and Founder, Branislav Vajdic, PhD.

Dear Fellow... More